Australia's largest stock trading and investment forum Australia's #1 stock forum

sorry green hydrogen goes back foot with Twiggy’s FMG!

First 14291 Last

Share
Profile

Follow
AJ7

15,924 Posts.

1166

05/08/24

21:35

Post #: 75081838
Share

Originally posted by AJ7: ↑

heyyyy you still there!!! Good to see you!!

I have HYT- white hydrogen gig in Kansas (pure punting) could be a jackpot of $1 north or nothing!
DMP- a sus FY25 and after that they are back to growth once improves unit economy of stores. Their annual report will be interesting to see!
ACW- my fav, phase 2 trail results soon then phase 3 and if FDA approves then another Telix. Alzheimer & Depression are $30b market & my wife is a doc, she said they can nail this…mid 2025- trail results will be ok then this stock will pull back for another raise for phase 3
OPT: let’s see if she goes to $3 in 18 months. They are at phase 3 and after that FDA. They did successful phase 2 in 2019. They got injection for blind people.
EOS: defense budget $100b and EOS is still at tip of ice berg. lockheed Martin, DRO, ASB all are ripping
APX- not big position,, only put 20k units at 49c..I think they can’t mess this up anymore!
AD8 was low ball $6 & still holding…it will be $50 stock in four years from the look of it…it is painful to see its retracements 60% from the top!
FMG- 30k reserve for below $15 entry
LLC with rate cuts will be a turn around…I liked their three years strategy…if they can roll out, stock price will double plus divis.
APA same, with white hydrogen goes back foot, renewables comes back into front foot with rate cutting environment.
ZIP as usual

Expand

sorry green hydrogen goes back foot with Twiggy’s FMG!
1 Upvote

Reply

Top Stories

ASX Market Open: ASX200 to open weak on Wall Street losses, as US investors factor in a lower Fed rate cut next month | October 8, 2024

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

There are more pages in this discussion • 72 more messages in this thread...

First 14291 Last

sorry green hydrogen goes back foot with Twiggy’s FMG!

ASX Market Open: ASX200 to open weak on Wall Street losses, as US investors factor in a lower Fed rate cut next month | October 8, 2024

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Featured News

Featured News

sorry green hydrogen goes back foot with Twiggy’s FMG!

Top Stories

ASX Market Open: ASX200 to open weak on Wall Street losses, as US investors factor in a lower Fed rate cut next month | October 8, 2024

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Featured News

Featured News